myositis
Information
- Disease name
- myositis
- Disease ID
- DOID:633
- Description
- "A myopathy characterized by muscle inflammation." [url:http\://www.nlm.nih.gov/medlineplus/myositis.html, url:https\://en.wikipedia.org/wiki/Myositis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03215927 | Active, not recruiting | Phase 2 | Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease | June 1, 2017 | July 30, 2023 |
| NCT02468895 | Active, not recruiting | MYOPROSP - a Prospective Cohort Study in Myositis | October 4, 2016 | December 2030 | |
| NCT01171573 | Active, not recruiting | Investigating Genes in Patients With Polymyositis and Dermatomyositis | January 2001 | December 2030 | |
| NCT00519103 | Completed | N/A | Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients | December 2002 | March 2003 |
| NCT00774462 | Completed | Phase 2 | Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis | January 2008 | December 2011 |
| NCT01432613 | Completed | N/A | Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies | December 22, 2010 | November 26, 2016 |
| NCT00001331 | Completed | Genetic and Family Studies of Inherited Muscle Diseases | May 1993 | March 2002 | |
| NCT00030212 | Completed | Immune Abnormalities in Sporadic Inclusion Body Myositis | February 4, 2002 | December 10, 2007 | |
| NCT00106184 | Completed | Phase 2 | Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) | March 2006 | August 2010 |
| NCT01734369 | Completed | Environmental Risk Factors for Myositis in Military Personnel | March 13, 2014 | ||
| NCT01790178 | Completed | N/A | Ultrasound in Muscle Biopsy | February 2013 | October 2015 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT02347891 | Completed | Phase 2/Phase 3 | Belimumab in Idiopathic Inflammatory Myositis | January 2015 | November 2020 |
| NCT02466217 | Completed | Phenomics in Autoimmune and Inflammatory Diseases | July 29, 2015 | July 18, 2022 | |
| NCT02501915 | Completed | Phase 1 | Kinesio Taping Effects Applied With Different Directions and Tensions | February 2014 | January 2015 |
| NCT03059394 | Completed | Validation of Rehab Assessments in Myositis Patients | March 2014 | May 2016 | |
| NCT03414086 | Completed | Predictor of Clinical Response to Acthar in Myositis | November 6, 2017 | July 30, 2022 | |
| NCT03440034 | Completed | Phase 1 | Study of Pioglitazone in Sporadic Inclusion Body Myositis | May 22, 2018 | December 31, 2020 |
| NCT03492242 | Completed | Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction | February 1, 2018 | September 30, 2018 | |
| NCT03713151 | Completed | N/A | Feasibility of a Blended Therapy Approach | February 27, 2019 | April 30, 2020 |
| NCT04486261 | Completed | N/A | High-intensity Strength Training in Myositis | August 30, 2021 | January 1, 2023 |
| NCT06300983 | Completed | N/A | Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being | September 15, 2022 | October 31, 2022 |
| NCT05692349 | Not yet recruiting | Magnetic Resonance Imaging and Ultrasonography in Evaluation of Muscle Diseases | January 2023 | January 2024 | |
| NCT06284954 | Not yet recruiting | Phase 2 | A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis | September 2024 | January 20, 2028 |
| NCT05979441 | Recruiting | Phase 3 | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy | September 12, 2023 | September 2027 |
| NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
| NCT03912428 | Recruiting | Phase 1 | Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis | June 14, 2019 | February 22, 2030 |
| NCT05895786 | Recruiting | Phase 3 | A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] | May 20, 2023 | July 23, 2026 |
| NCT05952531 | Recruiting | Early Phase 1 | Characterizing Myositis With 68Ga-FAPI PET/CT | July 1, 2023 | July 2025 |
| NCT05251415 | Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases | April 4, 2022 | April 4, 2032 | |
| NCT05379634 | Recruiting | Phase 2 | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies | July 5, 2022 | October 28, 2027 |
| NCT02450396 | Recruiting | Pregnancy and Medically Assisted Conception in Rare Diseases | June 2014 | December 2025 | |
| NCT05523167 | Recruiting | Phase 2/Phase 3 | A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. | October 12, 2022 | February 1, 2027 |
| NCT01276470 | Recruiting | Environmental Risk Factors for the Anti-synthetase Syndrome | February 9, 2011 | ||
| NCT05832034 | Recruiting | Phase 2 | Add-on Intravenous Immunoglobulins in Early Myositis | September 13, 2021 | September 2024 |
| NCT03937856 | Terminated | N/A | Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases | May 7, 2019 | April 22, 2021 |
| NCT04309227 | Terminated | N/A | Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations | May 1, 2021 | August 23, 2023 |
| NCT01184625 | Unknown status | N/A | Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation | January 2008 | August 2012 |
| NCT04367350 | Unknown status | Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement | March 20, 2020 | March 31, 2022 | |
| NCT04022655 | Unknown status | Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit | July 22, 2019 | October 2019 | |
| NCT01702870 | Unknown status | Diagnostic Accuracy of MR in Myositis | November 2012 | November 2014 | |
| NCT01501019 | Unknown status | N/A | Exercise in Sjogren, Myositis and Takayasu's Arteritis | October 2011 | |
| NCT05627089 | Withdrawn | Rheumatoid Arthritis and Myositis Cohort | July 1, 2023 | January 1, 2035 |
- Disase is a (Disease Ontology)
- DOID:423
- Cross Reference ID (Disease Ontology)
- ICD10CM:M60
- Cross Reference ID (Disease Ontology)
- MESH:D009220
- Cross Reference ID (Disease Ontology)
- MIM:160750
- Cross Reference ID (Disease Ontology)
- NCI:C27578
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:26889001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0027121
- Exact Synonym (Disease Ontology)
- Inflammatory disorder of muscle
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100614
- ICD10 preferred id (Insert disease from ICD10)
- D0010590
- ICD10 class code (Insert disease from ICD10)
- M60
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009220